Avinash Ravi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals promoters — Dr. R.T. Ravi, Mrs. Hemalata Ravi, Mr. Avinash Ravi, Mr. Aditya Ravi, and Mr. Ajay Ravi — have submitted a declaration to BSE and NSE under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The declaration confirms that the promoters and persons acting in concert have not created any encumbrance (such as pledge or lien) on their shares in the company during the financial year. This is a routine annual compliance filing required from promoters.
This is a neutral, routine compliance filing. The absence of any encumbrance means promoters have not pledged their shares, which slightly reduces any risk of forced selling due to margin calls. No material impact on stock price is expected.